MOLN.SW SIX
Molecular Partners AG
1W: +3.4%
1M: -4.9%
3M: +3.1%
YTD: -6.2%
1Y: +14.4%
3Y: -35.2%
5Y: -81.6%
CHF 3.33 ($4.02)
-0.01 (-0.30%)
Weekly Expected Move ±6.3%
CHF 3
CHF 3
CHF 3
CHF 4
CHF 4
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$2M
+95.0% ▲
Operating Income
-$55M
+9.4% ▲
Net Income
-$62M
-14.1% ▼
EPS (Diluted)
$-1.65
-3.8% ▼
EBITDA
-$53M
-3.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9M | $190M | $7M | $5M | $0 |
| YoY Growth | -0.1% | +1931.7% | -96.3% | -29.4% | -100.0% |
| Cost of Revenue | $56M | $51M | $48M | $48M | $2M |
| Gross Profit | -$46M | $139M | -$41M | -$43M | -$2M |
| Gross Margin | -497.2% | 73.2% | -579.8% | -855.8% | — |
| R&D Expenses | $56M | $51M | $49M | $49M | $0 |
| SG&A Expenses | $17M | $22M | $19M | $17M | $13M |
| Operating Expenses | $73M | $73M | $20M | $19M | $53M |
| Operating Income | -$63M | $117M | -$61M | -$61M | -$55M |
| Operating Margin | -679.7% | 61.5% | -868.3% | -1231.7% | — |
| Interest Expense | $556K | $619K | $49K | $38K | $4M |
| Income Before Tax | -$64M | $118M | -$62M | -$54M | -$62M |
| Tax Expense | $2K | -$717K | $0 | $2K | $2K |
| Net Income | -$64M | $118M | -$62M | -$54M | -$62M |
| Net Margin | -683.7% | 62.2% | -880.7% | -1087.4% | — |
| EPS (Diluted) | $-2.06 | $3.54 | $-1.89 | $-1.59 | $-1.65 |
| EBITDA | -$61M | $119M | -$60M | -$52M | -$53M |
| Shares Outstanding | 31M | 33M | 33M | 34M | 37M |